Cargando…
Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy
Atrial fibrillation is the most common sustained cardiac arrhythmia, and its prevalence is increasing with age; also it is associated with significant morbidity and mortality. Rhythm control is advised in recent-onset atrial fibrillation, and in highly symptomatic patients, also in young and active...
Autor principal: | Kossaify, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610431/ https://www.ncbi.nlm.nih.gov/pubmed/31320795 http://dx.doi.org/10.1177/1177392819861114 |
Ejemplares similares
-
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013) -
Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
por: Yan, He, et al.
Publicado: (2013) -
Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020) -
Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients
por: Rudiger, Alain, et al.
Publicado: (2014) -
Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study
por: Bager, Johan-Emil, et al.
Publicado: (2022)